Aerpio Therapeutics, Inc. — Form D

Aerpio Therapeutics, Inc. of CINCINNATI, OH, a company, filed a Form D exempt-offering notice with the SEC on 2014-05-06. The offering totals $22.0M, of which $22.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (25)

NameRoleLocation
Lauren H SilvermanDirectorCincinnati, OH
Robert H ShalwitzExecutive OfficerCincinnati, OH
John H RiceDirectorBethesda, MD
Ian AW HowesExecutive OfficerSeattle, WA
Joseph H GardnerDirectorCincinnati, OH
Joseph H GardnerExecutive OfficerCincinnati, OH
Paul H WeissDirectorCincinnati, OH
Campbell H MurrayDirectorCincinnati, OH
Duane H NashDirectorCincinnati, OH
Steve H PakolaExecutive OfficerCincinnati, OH
Reinhard H AmbrosDirectorCincinnati, OH
Anupam H DalalDirectorCincinnati, OH
Chau H KhuongDirectorCincinnati, OH
Adrienne H GravesDirectorCincinnati, OH
Kevin H PetersExecutive OfficerCincinnati, OH
Muneer H SatterDirectorCincinnati, OH
William H DalyExecutive OfficerCincinnati, OH
Alan H FishmanExecutive OfficerCincinnati, OH
Kevin AW PetersExecutive OfficerCincinnati, OH
Adrienne AW GravesDirectorCincinnati, OH
Campbell AW MurrayDirectorCincinnati, OH
John AW RiceDirectorCincinnati, OH
Robert AW ShalwitzExecutive OfficerCincinnati, OH
Anupam AW DalalDirectorCincinnati, OH
Paul AW WeissDirectorCincinnati, OH

Other filings by this issuer (6)

FiledFormOfferingSold
2016-11-14D$4.6M$3.5M
2016-04-15D$9.2M$4.5M
2013-11-15D/A$31.0M$27.0M
2013-09-12D/A$21.9M$18.0M
2012-11-16D$21.9M$10.0M
2012-01-05D$5.0M$5.0M

More